BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2667624)

  • 1. Molecular evidence of transient complete remission after autografting in Ph-/bcr rearranged chronic myelogenous leukaemia.
    Lo Coco F; Saglio G; De Fabritiis P; Diverio D; Guerrasio A; Rosso C; Meloni G; Mancini M; Mandelli F
    Br J Haematol; 1989 Jun; 72(2):285-6. PubMed ID: 2667624
    [No Abstract]   [Full Text] [Related]  

  • 2. [The assessment of therapeutic success in chronic myeloid leukemia].
    Griesshammer M; Hehlmann R; Heimpel H
    Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
    [No Abstract]   [Full Text] [Related]  

  • 3. Juvenile chronic myeloid leukaemia and alpha-interferon.
    Aricò M; Nespoli L; Caselli D; Bonetti F; Porta FA; Burgio GR
    Eur J Pediatr; 1989 Jan; 148(4):379-80. PubMed ID: 2707286
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.
    Mughal TI; Radich JP; Van Etten RA; Quintás-Cardama A; Skorski T; Ravandi F; DeAngelo DJ; Gambacorti-Passerini C; Martinelli G; Tefferi A
    Am J Hematol; 2011 Sep; 86(9):811-9. PubMed ID: 21850662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
    Valiente A; Outeriño J; Martín Calderín F; Benítez J
    Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia.
    Konstantinidou P; Szydlo RM; Chase A; Goldman JM
    Bone Marrow Transplant; 2000 Jan; 25(2):143-6. PubMed ID: 10673671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Philadelphia negative BCR-ABL positive chronic myeloid leukemia mimicking juvenile chronic myeloid leukemia in a 2-year-old child.
    Mahon FX; Labouyrie E; Aurich-Costa J; Dastugue N; Micheau M; Bady C; Perel Y; Bilhou-Nabera C; Reiffers J; Bernard P
    Leuk Lymphoma; 1997 Aug; 26(5-6):615-9. PubMed ID: 9389369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA analysis in chronic myelogenous leukemia, especially in clinical application of bcr gene rearrangement].
    Funato T; Bando Y; Ichikawa K; Ohtani H; Tokuhiro H
    Rinsho Byori; 1989 Mar; 37(3):306-10. PubMed ID: 2746921
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
    Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
    Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):425-7, 30. PubMed ID: 1660759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
    Kantarjian HM; Shtalrid M; Kurzrock R; Blick M; Dalton WT; LeMaistre A; Stass SA; McCredie KB; Gutterman J; Freireich EJ
    Am J Med; 1988 Nov; 85(5):639-44. PubMed ID: 3189367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.
    Cortes JE; Talpaz M; Beran M; O'Brien SM; Rios MB; Stass S; Kantarjian HM
    Cancer; 1995 Jan; 75(2):464-70. PubMed ID: 7812917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
    Quintás-Cardama A; Kantarjian H; Abruzzo LV; Cortes J
    Leukemia; 2007 Nov; 21(11):2394-6. PubMed ID: 17690707
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular analysis of Philadelphia chromosome positive leukaemias.
    Young BD
    Br J Cancer Suppl; 1988 Dec; 9():58-61. PubMed ID: 3076066
    [No Abstract]   [Full Text] [Related]  

  • 16. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute myeloblastic leukaemia without Philadelphia chromosome developing after interferon therapy for chronic myelocytic leukaemia with Philadelphia chromosome.
    Ohtsuka E; Kikuchi H; Abe Y; Moriyama K; Ohno E; Hirota K; Tezono K; Nasu M
    Br J Haematol; 1995 Aug; 90(4):951-3. PubMed ID: 7669678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pulsed field gel electrophoresis to characterize BCR gene involvement in CML patients lacking M-BCR rearrangement.
    Min GL; Martiat P; Pu GA; Goldman J
    Leukemia; 1990 Sep; 4(9):650-6. PubMed ID: 2395384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution with Philadelphia chromosome-negative recipient haematopoiesis early after allogeneic BMT for CML.
    Sill H; Rule SA; Joske DJ; Chase A; Lin F; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Mar; 17(3):453-5. PubMed ID: 8704706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.